Bausch Health Cos Current Ratio 2010-2024 | BHC

Bausch Health Cos current ratio from 2010 to 2024. Current ratio can be defined as a liquidity ratio that measures a company's ability to pay short-term obligations.
Bausch Health Cos Current Ratio Historical Data
Date Current Assets Current Liabilities Current Ratio
2024-09-30 $5.35B $4.51B 1.19
2024-06-30 $5.21B $4.37B 1.19
2024-03-31 $5.40B $4.41B 1.23
2023-12-31 $5.60B $4.30B 1.30
2023-09-30 $5.05B $4.22B 1.20
2023-06-30 $4.46B $3.97B 1.13
2023-03-31 $4.24B $3.92B 1.08
2022-12-31 $4.25B $3.94B 1.08
2022-09-30 $4.01B $3.83B 1.05
2022-06-30 $5.42B $5.00B 1.08
2022-03-31 $5.84B $4.77B 1.22
2021-12-31 $5.61B $5.20B 1.08
2021-09-30 $5.32B $5.44B 0.98
2021-06-30 $5.45B $5.52B 0.99
2021-03-31 $5.39B $4.90B 1.10
2020-12-31 $5.34B $4.91B 1.09
2020-09-30 $5.67B $4.73B 1.20
2020-06-30 $5.28B $4.72B 1.12
2020-03-31 $5.50B $4.89B 1.13
2019-12-31 $6.97B $6.25B 1.12
2019-09-30 $4.31B $3.74B 1.15
2019-06-30 $4.47B $3.71B 1.21
2019-03-31 $4.28B $3.94B 1.09
2018-12-31 $4.21B $3.84B 1.10
2018-09-30 $4.74B $4.16B 1.14
2018-06-30 $4.64B $4.07B 1.14
2018-03-31 $4.72B $3.99B 1.18
2017-12-31 $4.75B $4.27B 1.11
2017-09-30 $5.94B $4.73B 1.26
2017-06-30 $5.99B $4.47B 1.34
2017-03-31 $5.33B $4.25B 1.26
2016-12-31 $5.08B $3.61B 1.41
2016-09-30 $5.67B $3.90B 1.46
2016-06-30 $5.82B $4.23B 1.38
2016-03-31 $6.23B $4.60B 1.36
2015-12-31 $5.51B $5.31B 1.04
2015-09-30 $7.00B $4.65B 1.50
2015-06-30 $6.35B $4.29B 1.48
2015-03-31 $16.19B $3.10B 5.23
2014-12-31 $4.13B $2.71B 1.53
2014-09-30 $4.41B $3.14B 1.40
2014-06-30 $5.16B $2.50B 2.07
2014-03-31 $3.95B $2.56B 1.54
2013-12-31 $3.89B $2.51B 1.55
2013-09-30 $3.85B $2.85B 1.35
2013-06-30 $4.53B $1.76B 2.57
2013-03-31 $2.37B $1.65B 1.44
2012-12-31 $2.78B $1.82B 1.52
2012-09-30 $1.71B $1.16B 1.48
2012-06-30 $1.63B $1.05B 1.55
2012-03-31 $1.53B $0.96B 1.60
2011-12-31 $1.36B $0.92B 1.47
2011-09-30 $1.10B $0.86B 1.27
2011-06-30 $1.05B $0.76B 1.37
2011-03-31 $1.28B $0.66B 1.93
2010-12-31 $1.02B $0.69B 1.47
2010-09-30 $1.30B $0.85B 1.54
2010-06-30 $0.41B $0.23B 1.77
2010-03-31 $0.34B $0.21B 1.63
2009-12-31 $0.34B $0.25B 1.38
2009-09-30 $0.25B $0.22B 1.14
2009-06-30 $0.25B $0.22B 1.13
2009-03-31 $0.47B $0.23B 2.03
Sector Industry Market Cap Revenue
Medical Medical - Generic Drugs $3.597B $8.757B
Bausch Health Companies Inc. develops, manufactures and markets a wide array of branded, generic and branded generic pharmaceuticals, over-the-counter (OTC) products along with medical devices such as contact lenses, intraocular lenses, ophthalmic surgical equipment, and aesthetics devices in the therapeutic areas of eye-health, gastroenterology (GI), and dermatology.
Stock Name Country Market Cap PE Ratio
Teva Pharmaceutical Industries (TEVA) Israel $20.902B 7.10
Dr Reddy's Laboratories (RDY) India $12.399B 18.57
BridgeBio Pharma (BBIO) United States $4.791B 0.00
Amphastar Pharmaceuticals (AMPH) United States $2.469B 13.82
Supernus Pharmaceuticals (SUPN) United States $1.872B 377.44
Taysha Gene Therapies (TSHA) United States $0.314B 51.00
Personalis (PSNL) United States $0.270B 0.00
Assembly Biosciences (ASMB) United States $0.107B 0.00
Acasti Pharma (GRCE) Canada $0.031B 0.00
Sol-Gel Technologies (SLGL) Israel $0.014B 0.00
Evoke Pharma (EVOK) United States $0.005B 0.00
Teligent (TLGT) United States $0.000B 0.00